Testing effectiveness (Phase 2)Active Not RecruitingNCT03787680
What this trial is testing
Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 49